December 21, 2022
Discover our last publication
Have you ever considered using FTIR to investigate your antibodies?
These new biosensors could allow us to monitor higher-order structure and aggregation of biotherapeutics during production by exploiting the advantages of FTIR spectroscopy before the purification step.
Check out this new publication from Université libre de Bruxelles in collaboration with Spectralys here: https://pubmed.ncbi.nlm.nih.gov/36233197/